Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CPA3 | P15088 | 1/20 | 0.63 |
| ▸ | FOLH1 | Q04609 | 4/20 | 0.60 |
| ▸ | LAP3 | P28838 | 3/20 | 0.53 |
| ▸ | ERAP2 | Q6P179 | 3/20 | 0.53 |
| ▸ | ERAP1 | Q9NZ08 | 2/20 | 0.53 |
| ▸ | ANPEP | P15144 | 2/20 | 0.53 |
| ▸ | GRM3 | Q14832 | 2/20 | 0.51 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5052894 | 0.83 | CPA3 (0.71) | CPA3FOLH1LAP3ERAP2ERAP1 | |
| SCHEMBL5054470 | 0.80 | FOLH1 (0.56) | CPA3FOLH1GRM3NAALAD2 | |
| SCHEMBL14325899 | 0.79 | CPA3 (0.69) | CPA3FOLH1LAP3ERAP2ERAP1 | |
| SCHEMBL29088272 | 0.78 | CPA3 (1.00) | CPA3FOLH1NAALAD2 | |
| SCHEMBL3963424 | 0.78 | CPA3 (1.00) | CPA3FOLH1NAALAD2 | |
| SCHEMBL1373664 | 0.78 | GRM3 (0.65) | CPA3FOLH1GRM3 | |
| SCHEMBL12145183 | 0.77 | GRM3 (0.68) | CPA3FOLH1GRM3 | |
| SCHEMBL5134212 | 0.76 | FOLH1 (0.62) | CPA3FOLH1GRM3 | |
| SCHEMBL5134379 | 0.76 | FOLH1 (0.65) | CPA3FOLH1GRM3 | |
| SCHEMBL13946447 | 0.76 | GRM3 (0.57) | CPA3FOLH1GRM3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1999033848-B1 | PROCESS FOR PREPARING ENANTIOMER-ENRICHED HYDROXYPHOSPHINYL DERIVATIVES | GUILFORD PHARM INC (US) | 1999-08-12 | — | — | WO | claimed |